By scientists, for scientists.

We started Messenger Bio because thousands of human diseases remain unsolved, and the discovery of new medicines still takes too long. Scientists need better access to foundational drug discovery technologies so they can get to the point of translation faster.

We build differentiated, high-value biotechnology product platforms that make it easier for scientists to do their best work. mRNA is our starting point. By partnering with scientists early on in their research journey, we aim to accelerate the deployment of groundbreaking new products, from vaccines to curative gene-editing medicines.

 
Denzil FurtadoDenzil Furtado is a 2020 Westpac Future Leaders Scholar and PhD candidate in the Department of Chemical Engineering at the University of Melbourne. He specializes in the engineering, synthesis, and purification of mRNA for therapeutic applications, as well as the formulation of novel materials for the delivery of nucleic acids.

Denzil Furtado, Ph.D.

Co-founder &
CEO

Professor Frank Caruso FRS FAA is a Melbourne Laureate Professor and NHMRC Senior Principal Research Fellow in the Department of Chemical Engineering at the University of Melbourne, Australia. For the past three decades he has conducted research at the frontiers of nano- and biotechnology, leveraging cutting edge materials science to develop nanoparticles for biomedical drug delivery applications.

Prof. Frank Caruso

Co-founder &
Scientific Advisor

 
 

Want to partner with us or join the team?
Email us at hello@messenger.bio